PMC:7463108 / 83492-83749
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T801 | 4-8 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T802 | 170-173 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T803 | 213-223 | Body_part | denotes | astrocytes | http://purl.org/sig/ont/fma/fma54537 |
T804 | 232-241 | Body_part | denotes | microglia | http://purl.org/sig/ont/fma/fma68923 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T863 | 4-13 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell type |
T864 | 79-80 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T865 | 213-223 | http://purl.obolibrary.org/obo/CL_0000127 | denotes | astrocytes |
T866 | 232-241 | http://purl.obolibrary.org/obo/CL_0000129 | denotes | microglia |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T17870 | 90-96 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T86945 | 111-120 | Chemical | denotes | maraviroc | http://purl.obolibrary.org/obo/CHEBI_63608 |
T279 | 134-151 | Chemical | denotes | opioid antagonist | http://purl.obolibrary.org/obo/CHEBI_60605 |
T83127 | 141-151 | Chemical | denotes | antagonist | http://purl.obolibrary.org/obo/CHEBI_48706 |
T281 | 153-163 | Chemical | denotes | naltrexone | http://purl.obolibrary.org/obo/CHEBI_7465 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2937 | 44-48 | Gene | denotes | CCR5 | Gene:1234 |
2938 | 53-56 | Gene | denotes | MOR | Gene:4988 |
2949 | 246-250 | Gene | denotes | Hage | Gene:55510 |
2950 | 170-175 | Species | denotes | HIV-1 | Tax:11676 |
2955 | 153-163 | Chemical | denotes | naltrexone | MESH:D009271 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1129 | 0-257 | Sentence | denotes | The cell type specific interactions between CCR5 and MOR were noted when using a bivalent ligand derivative of maraviroc linked to an opioid antagonist, naltrexone, with HIV-1 entry being significantly blocked in astrocytes but not microglia (El-Hage et al. |